CLEC4A and neoplasm: Moreover, frequencies of CLR-expressing pDCs in patient’s blood were positioned in a separate area of the PCA analysis (based on PC1 and PC2) when compared to HD blood and/or tumor infiltrate (Figure 3C; left panel; Supplementary Figure 6B), and this distinction seemed to mostly be driven by DCIR and FcɣRIIα expression (Figure 3C; right panel).